Norbrook is expanding their popular NSAID range with the launch of Loxicom Injection for Cattle, Pigs and Horses. The new product offers treatment for a range of symptoms including pneumonia, acute mastitis and calf scour in cattle, swine locomotor diseases such as lameness and MMA syndrome, acute and chronic musculo-skeletal disorders and equine colic.
“Loxicom is our tried and trusted NSAID range which has been available in suspension or injection for cats and dogs and which has proven exceptionally popular with veterinary practices. According to the GFK data,
Norbrook is the most successful generic manufacturer of Meloxicam, by some distance,” explains Rebecca Pullon, Norbrook Product Manager. “I am delighted that we can now extend this range to include a Loxicom Injection for Cattle, Pigs and Horses, which I am confident will prove equally as popular.”
Loxicom, Norbrook’s meloxicam product, is of course bio-equivalent to the pioneer product, with a proven track record for efficacy and safety.
Norbrook manufactures pharmaceutical products for almost all veterinary pharmaceutical multinationals. The development and registration of such generic products face the rigors of contemporaneous standards on quality, safety and efficacy that must be attained to achieve a marketing authorization.
“As a bio-equivalent product, Loxicom Injection for Cattle, Pigs and Horses is as effective as the pioneer product,” adds Ms Pullon. “There is a misperception that a bioequivalent product is somehow inferior to the pioneer product, which is untrue. In order to attain a license, a company must prove that a bio-equivalent product is at least as effective as the pioneer.
With Loxicom Injection for Cattle, Pigs and Horses, it comes with the added reassurance that it has been produced by Norbrook, a world leader in animal health and veterinary pharmaceuticals manufacture.”
Norbrook’s Loxicom range includes an oral suspension and an injection for dogs and cats. Loxicom Injection for Cattle, Pigs and Horses will be available from mid-October. All of Norbrook’s VMD licensed product data sheets are available both on the Norbrook website, and also via Norbrook’s innovative iPhone app, now available for free download from the iTunes Store.
Norbrook is a leading global veterinary pharmaceutical manufacturer, licensed by the majority of the world’s governments, including the USFDA who has granted Norbrook a license to manufacture sterile injectable outside the United States for import and sale throughout the country.
Norbrook is the only company in the world who has been granted such a license by the USFDA. “Norbrook is extremely proud of our FDA approval and regard it as an indication of the quality and standards of our manufacturing, licensing and regulatory expertise,” comments Jorge Rodrigues, Norbrook GB General Manager. “We are a leading generic company for small animal products according to GFK data, which is something we are also very proud of.”